4th Quarter - Amendment
DEXCOM, INC. for DEXCOM, INC.
Firm
Client
Income
—
Expenses
$57,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 6, 2022 | — | Replaced |
| 4th Quarter - Amendment | Jan 6, 2022 | — | Replaced |
| 4th Quarter - Amendment (this page) | Mar 23, 2022 | $57,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Coverage policy for advanced diabetes technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE THOMAS TAYLOR | — |
Medicare/Medicaid MMM
CMS Coverage Policy for advanced diabetes technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE THOMAS TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.